Cypherpunk Technologies Inc.

NasdaqCM:CYPH Stock Report

Market Cap: US$99.7m

Cypherpunk Technologies Management

Management criteria checks 3/4

Cypherpunk Technologies' CEO is Doug Onsi, appointed in Jan 2011, has a tenure of 14.83 years. total yearly compensation is $1.48M, comprised of 47.5% salary and 52.5% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth $247.93K. The average tenure of the management team and the board of directors is 5.3 years and 8.8 years respectively.

Key information

Doug Onsi

Chief executive officer

US$1.5m

Total compensation

CEO salary percentage47.45%
CEO tenure14.8yrs
CEO ownership0.2%
Management average tenure5.3yrs
Board average tenure8.8yrs

Recent management updates

Recent updates

Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Deliver On Growth Plans?

Mar 13
Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Deliver On Growth Plans?

Will Leap Therapeutics (NASDAQ:LPTX) Spend Its Cash Wisely?

Nov 22
Will Leap Therapeutics (NASDAQ:LPTX) Spend Its Cash Wisely?

Leap Therapeutics GAAP EPS of -$0.15 misses by $0.05

Aug 12

Leap Therapeutics begins trials of DKN-01 in gastric/colorectal cancers

Jul 12

Leap Therapeutics: 2 Catalysts With Cancer Drug DKN-01 In The 2nd Half Of 2022

Jun 27

Here's Why We're Watching Leap Therapeutics' (NASDAQ:LPTX) Cash Burn Situation

May 01
Here's Why We're Watching Leap Therapeutics' (NASDAQ:LPTX) Cash Burn Situation

Leap Therapeutics: Waiting For One More Leap

Feb 18

We're Hopeful That Leap Therapeutics (NASDAQ:LPTX) Will Use Its Cash Wisely

Jan 04
We're Hopeful That Leap Therapeutics (NASDAQ:LPTX) Will Use Its Cash Wisely

Leap Therapeutics: What Prompted Prioritizing This Precision Oncology Company?

Nov 29

Leap Therapeutics: All On The Line

Oct 13

Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?

Sep 15
Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?

Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?

Jun 01
Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?

Companies Like Leap Therapeutics (NASDAQ:LPTX) Are In A Position To Invest In Growth

Mar 03
Companies Like Leap Therapeutics (NASDAQ:LPTX) Are In A Position To Invest In Growth

Could The Leap Therapeutics, Inc. (NASDAQ:LPTX) Ownership Structure Tell Us Something Useful?

Jan 27
Could The Leap Therapeutics, Inc. (NASDAQ:LPTX) Ownership Structure Tell Us Something Useful?

Announcing: Leap Therapeutics (NASDAQ:LPTX) Stock Increased An Energizing 127% In The Last Year

Dec 23
Announcing: Leap Therapeutics (NASDAQ:LPTX) Stock Increased An Energizing 127% In The Last Year

Need To Know: Analysts Are Much More Bullish On Leap Therapeutics, Inc. (NASDAQ:LPTX)

Nov 18
Need To Know: Analysts Are Much More Bullish On Leap Therapeutics, Inc. (NASDAQ:LPTX)

CEO Compensation Analysis

How has Doug Onsi's remuneration changed compared to Cypherpunk Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-US$51m

Jun 30 2025n/an/a

-US$66m

Mar 31 2025n/an/a

-US$70m

Dec 31 2024US$1mUS$703k

-US$68m

Sep 30 2024n/an/a

-US$65m

Jun 30 2024n/an/a

-US$60m

Mar 31 2024n/an/a

-US$53m

Dec 31 2023US$2mUS$669k

-US$81m

Sep 30 2023n/an/a

-US$81m

Jun 30 2023n/an/a

-US$82m

Mar 31 2023n/an/a

-US$86m

Dec 31 2022US$2mUS$637k

-US$55m

Sep 30 2022n/an/a

-US$53m

Jun 30 2022n/an/a

-US$49m

Mar 31 2022n/an/a

-US$42m

Dec 31 2021US$2mUS$596k

-US$41m

Sep 30 2021n/an/a

-US$37m

Jun 30 2021n/an/a

-US$32m

Mar 31 2021n/an/a

-US$29m

Dec 31 2020US$2mUS$513k

-US$38m

Sep 30 2020n/an/a

-US$39m

Jun 30 2020n/an/a

-US$40m

Mar 31 2020n/an/a

-US$42m

Dec 31 2019US$817kUS$400k

-US$33m

Sep 30 2019n/an/a

-US$24m

Jun 30 2019n/an/a

-US$22m

Mar 31 2019n/an/a

-US$21m

Dec 31 2018US$682kUS$400k

-US$23m

Compensation vs Market: Doug's total compensation ($USD1.48M) is above average for companies of similar size in the US market ($USD582.44K).

Compensation vs Earnings: Doug's compensation has been consistent with company performance over the past year.

CEO

Doug Onsi (56 yo)

14.8yrs
Tenure
US$1,481,782
Compensation

Mr. Douglas E. Onsi, also known as Doug, J.D., serves as Director at Cypherpunk Technologies Inc. (formerly known as Leap Therapeutics, Inc.) since March 18, 2020. He serves as Managing Director of HCV Man...

Leadership Team

NamePositionTenureCompensationOwnership
Douglas Onsi
CFO, General Counsel14.8yrsUS$1.48m0.25%
$ 247.9k
Will McEvoy
Chief Investment Officer & Directorno datano datano data
Jason Baum
Chief Scientific Officer2.6yrsno data0.028%
$ 28.0k
Mark O'Mahony
Chief Manufacturing Officer5.6yrsno data0.049%
$ 48.4k
Christine Granfield
VP and Head of Regulatory Affairs & Quality5.3yrsno data0.028%
$ 28.0k
5.3yrs
Average Tenure
55yo
Average Age

Experienced Management: CYPH's management team is seasoned and experienced (5.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Douglas Onsi
CFO, General Counsel5.7yrsUS$1.48m0.25%
$ 247.9k
Will McEvoy
Chief Investment Officer & Directorno datano datano data
Christopher Mirabelli
Director14.8yrsno data0.037%
$ 36.8k
James Cavanaugh
Independent Director9.8yrsUS$163.06k0.00038%
$ 378.9
Thomas Dietz
Lead Independent Director9.8yrsUS$243.38k0%
$ 0
Nissim Mashiach
Independent Director8.8yrsUS$153.48k0%
$ 0
Joseph Loscalzo
Independent Director9.8yrsUS$148.56k0%
$ 0
William Li
Independent Director8.8yrsUS$158.06k0%
$ 0
Carl Nathan
Member of Scientific Advisory Boardno datano datano data
Khing Oei
Chairman of the Boardno datano datano data
David Tuveson
Member of Scientific Advisory Boardno datano datano data
Andrew Nixon
Member of Scientific Advisory Board4.8yrsno datano data
8.8yrs
Average Tenure
64yo
Average Age

Experienced Board: CYPH's board of directors are considered experienced (8.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/14 13:53
End of Day Share Price 2025/11/14 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cypherpunk Technologies Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Swayampakula RamakanthH.C. Wainwright & Co.
Wangzhi LiLadenburg Thalmann & Company
Tyler Van BurenPiper Sandler Companies